| 摘要 |
A method of monitoring treatment of HCV by oral administration of ovine IFN- tau is disclosed. The method includes measuring the blood levels of 2', 5'-oligoadenylate synthetase prior to and after such oral administration, and if necessary, adjusting the dose of IFN- tau until a measurable increase in blood 2', 5'-oligoadenylate synthetase level, relative to the level observed prior to administration, is observed. Also disclosed are oral-delivery compositions for use in treating HCV in an HCV-infected patient comprising ovine IFN- tau , in a dosage effective to stimulate bloodstream levels of 2', 5'-oligoadenylate synthetase. |
